Foster City, CA, United States of America

Lukas C Amler

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 61(Granted Patents)


Location History:

  • Pennington, NJ (US) (2009)
  • Foster City, CA (US) (2009 - 2021)

Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Impact of Inventor Lukas C Amler

Introduction

Lukas C Amler, based in Foster City, California, is an accomplished inventor with a commendable portfolio of six patents. His work mainly focuses on the genetic underpinnings of drug resistance in cancer treatment. Throughout his career, he has contributed significantly to advancements in medical science, particularly in oncology.

Latest Patents

Among Lukas's latest patents is a groundbreaking invention related to "Genetic variations associated with drug resistance." He provides methods and compositions to determine whether a cancer is resistant to treatment with anti-mitotic agents, including T-DM1. These methods focus on assessing the amplification and/or overexpression of the ABCC3 gene in cancer cells, which is crucial for understanding treatment efficacy.

Career Highlights

Lukas C Amler has had a remarkable career, with professional stints at notable companies such as Genentech, Inc. and Hoffmann-La Roche Inc. His roles at these leading organizations have allowed him to innovate and expand his expertise in drug development and genetic research.

Collaborations

Amler has collaborated with esteemed colleagues such as Merrill Birkner and Chin-Yu Lin. Together, they have worked on pioneering projects aimed at improving cancer treatment outcomes, reinforcing the importance of teamwork in scientific advancements.

Conclusion

Lukas C Amler's contributions to the field of medicine through his patents and collaborations illustrate his commitment to addressing pressing health challenges. His innovative approaches to understanding drug resistance in cancer will undoubtedly continue to influence future research and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…